meantime companies queueing cracks amyloid eli lilly spent billions failed alzheimer drugs recent years designed trial test amyloid hypothesis definitive way possible said mark mintun company vice president neurodegeneration plan bace inhibitor pair injected treatment targets amyloid brain address major concerns approach mintun said bace inhibitors prevent amyloid not address plaques exist amyloid targeting therapies not stem flow new toxic clumps equate going basement finding feet water slow drip weeks mintun said turn spigot will not feel like progress got pump study enrolling 375 patients groups planning study combination improve cognition compared placebo 18 months stat delivers fast deep tough